Selective MHC expression in tumours modulates adaptive and innate antitumour responses.
about
The Walker 256 Breast Cancer Cell- Induced Bone Pain Model in RatsAre BiTEs the "missing link" in cancer therapy?Survivin-derived peptide epitopes and their role for induction of antitumor immunity in hematological malignanciesHuman leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 productionCutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system.Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responsesProximity ligation assay evaluates IDH1R132H presentation in gliomasNK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironmentVSIG4 is highly expressed and correlated with poor prognosis of high-grade glioma patients.MHC class I and class II molecules are expressed in both human and mouse prostate tumor microenvironment.Immunoepigenetics: the unseen side of cancer immunoediting.On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases.Innate immune cells in breast cancer--from villains to heroes?Equine herpesvirus type 1-mediated oncolysis of human glioblastoma multiforme cells.Oncoprotein suppression of tumor necrosis factor-induced NF kappa B activation is independent of Raf-controlled pathways.Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression.Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas.
P2860
Q28075980-954BD298-589F-4233-818A-9A79B787B0E8Q28083907-D588D2A0-67E5-4311-A520-3FC085AE3838Q28251858-A31C0E98-26CC-4036-B0A1-3EBC79432C91Q28350682-20D17733-7700-4F87-A435-200E4FC6C9A2Q30235983-97F660E6-1189-44B5-B024-0A03859A5D56Q33620107-05F2F763-E1AF-4687-8768-18E829B9D215Q35056736-D3CD1F96-8E42-4A17-8829-27088820D882Q35915642-636AC77D-3E69-4CB6-BADE-2B76D895B580Q35941343-B7561F91-FC6F-47C2-885F-C553A12B8987Q36513540-9F8CBA6B-6186-4103-B84E-77D347CDC74DQ36666346-4F77CBF8-C095-4E64-8499-8FF338D76B7AQ37354975-9A9F6710-E18B-4F13-90A3-7A66055D75EEQ37905673-B8578F59-E521-44AE-B015-C7CA9F4CD7BDQ39420986-486637C6-993E-4E9A-B7E2-27A90B8CE3E6Q43990096-5A29813F-CEE7-4F6A-AB07-BAD9EDC7F9E4Q45201798-1E7179C8-C3FB-46CE-8A60-1ACA83537DCDQ53294096-6AC7E449-0D38-475C-B03D-CF65738D862C
P2860
Selective MHC expression in tumours modulates adaptive and innate antitumour responses.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Selective MHC expression in tumours modulates adaptive and innate antitumour responses.
@ast
Selective MHC expression in tumours modulates adaptive and innate antitumour responses.
@en
type
label
Selective MHC expression in tumours modulates adaptive and innate antitumour responses.
@ast
Selective MHC expression in tumours modulates adaptive and innate antitumour responses.
@en
prefLabel
Selective MHC expression in tumours modulates adaptive and innate antitumour responses.
@ast
Selective MHC expression in tumours modulates adaptive and innate antitumour responses.
@en
P356
P1476
Selective MHC expression in tumours modulates adaptive and innate antitumour responses.
@en
P2888
P304
P356
10.1007/S002620050589
P577
1999-10-01T00:00:00Z
P6179
1045560921